JPH045290A - New adenine derivative - Google Patents

New adenine derivative

Info

Publication number
JPH045290A
JPH045290A JP10660590A JP10660590A JPH045290A JP H045290 A JPH045290 A JP H045290A JP 10660590 A JP10660590 A JP 10660590A JP 10660590 A JP10660590 A JP 10660590A JP H045290 A JPH045290 A JP H045290A
Authority
JP
Japan
Prior art keywords
acid
general formula
adenine
methoxy
adenine derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP10660590A
Other languages
Japanese (ja)
Other versions
JP3019360B2 (en
Inventor
Akinori Oda
小田 晃規
Takehito Maruyama
岳人 丸山
Takashi Suzuki
隆 鈴木
Akinobu Tanaka
昭宣 田中
Shigeo Yoshinaka
吉中 茂生
Takashi Oritani
折谷 隆志
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Gas Chemical Co Inc
Original Assignee
Mitsubishi Gas Chemical Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Gas Chemical Co Inc filed Critical Mitsubishi Gas Chemical Co Inc
Priority to JP2106605A priority Critical patent/JP3019360B2/en
Publication of JPH045290A publication Critical patent/JPH045290A/en
Application granted granted Critical
Publication of JP3019360B2 publication Critical patent/JP3019360B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。
(57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.

Description

【発明の詳細な説明】 [産業上の利用分野コ 本発明は、新規なアデニン誘導体に関する。本発明に係
るアデニン誘導体は、サイトカイニン活性を示し、植物
の細胞分裂促進、側芽の生長促進、発芽促進、花芽形成
と開花の促進、着果促進、果実肥大、老化抑制および貯
蔵器官における物質蓄積促進等の植物生理作用の活性促
進に有用な物質である。
DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention relates to novel adenine derivatives. The adenine derivative according to the present invention exhibits cytokinin activity, promotes cell division in plants, promotes growth of lateral buds, promotes germination, promotes flower bud formation and flowering, promotes fruit set, enlarges fruits, suppresses aging, and promotes substance accumulation in storage organs. It is a substance useful for promoting the activity of plant physiological functions such as.

〔従来の技術、発明が解決しようとする問題点〕従来、
植物、殊に、穀物、果物、野菜の生育を調節するために
、数多くの化合物が見いだされている。なかでも、サイ
トカイニンと総称される物質群に属するものには、多く
の生理作用が知られており、代表的な化合物として、ゼ
アチン、カイネチンおよびベンジルアデニンなどがある
。このようなサイトカイニンは、植物の細胞分裂促進、
側芽の生長促進、発芽促進、花芽形成と開花の促進、着
果促進、果実肥大、老化抑制および貯蔵器官における物
質蓄積促進等の植物生理作用が知られている。
[Prior art, problems to be solved by the invention] Conventionally,
Numerous compounds have been found to regulate the growth of plants, especially grains, fruits, and vegetables. Among these, substances belonging to the group of substances collectively called cytokinins are known to have many physiological effects, and representative compounds include zeatin, kinetin, and benzyladenine. These cytokinins promote cell division in plants,
It is known to have physiological effects on plants such as promoting the growth of lateral buds, promoting germination, promoting flower bud formation and flowering, promoting fruit set, fruit enlargement, suppressing aging, and promoting substance accumulation in storage organs.

従来、サイトカイニン活性を示す物質は天然に存在する
が、天然物ではその量も限られているし、また入手も容
易でない。また、サイトカイニン活性を示す物質が多く
の生理作用を有する割には実用面での用途が限られてい
るのが現状である。
Substances exhibiting cytokinin activity have conventionally existed in nature, but the amount of these natural products is limited and they are not easily available. Furthermore, although substances exhibiting cytokinin activity have many physiological effects, their practical applications are currently limited.

この実用面での用途が限られている原因の一つに、従来
知られているサイトカイニンは、水に対する溶解性に乏
しく、植物への吸収、他の器官への転流が充分でないこ
とが挙げられる。
One of the reasons for this limited practical use is that conventionally known cytokinins have poor solubility in water, and are not sufficiently absorbed into plants or translocated to other organs. It will be done.

本発明は、従来の合成によるサイトカイニンよりも水溶
性に富み、また、天然のサイトカイニンよりも入手が容
易なサイトカイニン活性を示す合成物質を提供するにあ
る。
The object of the present invention is to provide a synthetic substance exhibiting cytokinin activity that is more water-soluble than conventionally synthesized cytokinin and more easily available than natural cytokinin.

[問題点を解決するための手段] 本発明者らは、前述の事情に鑑み、サイトカイニン活性
を示すとともに、水溶性を有する化合物について数多く
の研究、検討を重ねた結果、アデニンのN6窒素原子に
下記の式Aで示されるような側鎖を有する新規なアデニ
ン誘導体およびこれらの塩が有効であることを見いだし
本発明に到達した。
[Means for Solving the Problems] In view of the above-mentioned circumstances, the present inventors have conducted numerous studies and studies on compounds that exhibit cytokinin activity and are water-soluble. The present invention was achieved by discovering that novel adenine derivatives having a side chain as shown in the following formula A and their salts are effective.

CH3 / (CH2)、−N         [:A)\ CH3 すなわち、本発明は、下記の一般式■および一般式■で
示されるアデニン誘導体およびその塩に(ただし、−船
蔵Iおよび一般式■において、nは2または3の整数、
Xは水素または塩素原子、Yは水素原子または2−リボ
シル基を示す。ただし、XとYがともに水素原子の場合
を除く。
CH3/(CH2), -N [:A)\CH3 That is, the present invention relates to adenine derivatives and salts thereof represented by the following general formulas ■ and general formulas (provided that in -Shinzo I and general formula ■) , n is an integer of 2 or 3,
X represents a hydrogen atom or a chlorine atom, and Y represents a hydrogen atom or a 2-ribosyl group. However, this excludes the case where both X and Y are hydrogen atoms.

船蔵■において、2は当量の塩酸、臭化水素酸、硫酸、
硝酸、りん酸、ギ酸または酢酸である。)本発明に係る
上記の一般式■で示されるアデニン誘導体は、たとえば
、次のような方法により得ることができる。
In the ship's warehouse, 2 contains equivalent amounts of hydrochloric acid, hydrobromic acid, sulfuric acid,
Nitric acid, phosphoric acid, formic acid or acetic acid. ) The adenine derivative represented by the above general formula (2) according to the present invention can be obtained, for example, by the following method.

2.6−ジクロロプリンまたは6−クロロプリンリボシ
ドと下記の式Bで示される構造を有するアミン誘導体と
を、たとえばアルコール類等の有機溶媒中で、トリアル
キルアミン(たとえば、トリエチルアミンまたはエチル
ジイソプロピルアミン)の存在下に加熱し、反応させる
ことにより合成できる。
2.6-dichloropurine or 6-chloropurine riboside and an amine derivative having a structure represented by the following formula B are mixed with a trialkylamine (for example, triethylamine or ethyldiisopropylamine) in an organic solvent such as an alcohol. ) can be synthesized by heating and reacting in the presence of

OCH。OCH.

/ NH2(CH2)l、  N        (:B)
\  H3 (ただし、nは2または3の整数である)−船蔵■で示
される本発明のアデニン誘導体を高純度で得るには、先
ず式Bで示されるアミン誘導体を高純度で得ることが大
切である。弐Bで示されるアミン誘導体を高純度で得る
方法としては、たとえば、N、0−ジメチルヒドロキシ
ルアミンとN−(ハロアルキル)フタルイミドとを反応
させて、式Bで示されるアミンのフタルイミド誘導体を
得、これを加水分解する方法がある。この場合、2,6
−ジクロロプリンまたは6−クロロプリンリボシドとの
反応に当たり、式Bのアミンを単離することなく、加水
分解反応液を用いて26−ジクロロプリンまたは6−ク
ロロプリンリボシドと反応させることもできる。
/ NH2(CH2)l, N (:B)
\ H3 (However, n is an integer of 2 or 3) - Onboard In order to obtain the adenine derivative of the present invention represented by ■ in high purity, it is first necessary to obtain the amine derivative represented by formula B in high purity. It's important. A method for obtaining the amine derivative represented by formula B with high purity is, for example, by reacting N,0-dimethylhydroxylamine and N-(haloalkyl)phthalimide to obtain a phthalimide derivative of the amine represented by formula B, There is a way to hydrolyze this. In this case, 2,6
- In the reaction with dichloropurine or 6-chloropurine riboside, it is also possible to react with 26-dichloropurine or 6-chloropurine riboside using a hydrolysis reaction solution without isolating the amine of formula B. .

本発明に係る一般式Iで表されるアデニン誘導体の代表
例としては、 つぎの式■で表される2−クロロ−N6−[2−(N−
メトキシ−N−メチルアミノ)エチルコアデニン、式■
で表される2−クロロ−N’−[3−(N−メトキシ−
N−メチルアミノ)プロピル]アデニン、式■で表され
るN6− [2−(N−メトキシ−N−メチルアミノ)
エチルコアデニンリボシドが挙げられる。
A typical example of the adenine derivative represented by the general formula I according to the present invention is 2-chloro-N6-[2-(N-
Methoxy-N-methylamino)ethylcoadenine, formula ■
2-chloro-N'-[3-(N-methoxy-
N-methylamino)propyl]adenine, N6-[2-(N-methoxy-N-methylamino) represented by the formula ■
Ethylcoadenine riboside is mentioned.

また、本発明に係るアデニン誘導体は、通常の方法によ
り容易に次の一般式■で表される塩酸、臭化水素酸、硫
酸、硝酸、りん酸などの鉱酸塩あるいはギ酸、酢酸など
の有機酸塩の形とすることができる。
In addition, the adenine derivative according to the present invention can be easily obtained by a conventional method using mineral acid salts such as hydrochloric acid, hydrobromic acid, sulfuric acid, nitric acid, and phosphoric acid, or organic acids such as formic acid and acetic acid. It can be in the form of an acid salt.

(ただし、nは2または3の整数、Xは水素または塩素
原子、Yは水素原子または2−リボシル基を示す。ただ
し、XとYがともに水素原子の場合を除く。Zは当量の
塩酸、臭化水素酸、硫酸、硝酸、りん酸、ギ酸または酢
酸である。)具体的には、たとえば下記の式■で表され
る2−クロロ−N’ −[2−(N−メトキシ−N−メ
チルアミノ)エチル]アデニンの塩酸塩が挙げら本発明
における一般式■で表されるアデニン誘導体および、−
船蔵■で表されるアデニン誘導体の塩の物性を表−1に
示す。
(However, n is an integer of 2 or 3, X is a hydrogen or chlorine atom, and Y is a hydrogen atom or a 2-ribosyl group. However, this excludes cases where both X and Y are hydrogen atoms. Hydrobromic acid, sulfuric acid, nitric acid, phosphoric acid, formic acid or acetic acid.) Specifically, for example, 2-chloro-N'-[2-(N-methoxy-N- [methylamino)ethyl] adenine hydrochloride, an adenine derivative represented by the general formula (■) in the present invention, and -
Table 1 shows the physical properties of the adenine derivative salt represented by Shipura (■).

2   IV  3  CIH、、−230〜231(
分解)3    V   2  Hribs −127
〜1294   VI  2  [1’lHHCl18
2〜184(分解)本発明に係る前記−船蔵■で表され
るアデニン誘導体および一般式■で表されるアデニン誘
導体の塩は、植物ホルモン、サイトカイニン活性を有す
るもので、植物生長調節剤として圃場で使用したり、あ
るいは植物組織培養用の培地成分などとして利用できる
ことが期待される。
2 IV 3 CIH, -230 to 231 (
Decomposition) 3 V 2 Hribs -127
~1294 VI 2 [1'lHHCl18
2-184 (Degradation) The adenine derivative represented by the above-mentioned ship stock (■) and the salt of the adenine derivative represented by the general formula (■) according to the present invention have plant hormone and cytokinin activity, and can be used as plant growth regulators. It is expected that it can be used in fields or as a medium component for plant tissue culture.

次に、本発明に係るアデニン誘導体の合成、ならびにそ
の生理活性について、実施例および試験例を示す。
Next, Examples and Test Examples will be shown regarding the synthesis of the adenine derivative according to the present invention and its physiological activity.

[実施例] 本発明を実施例によりさらに具体的に説明するが、本発
明はこれらの実施例に限定されるものではない。
[Examples] The present invention will be explained in more detail with reference to Examples, but the present invention is not limited to these Examples.

実施例1 2−クロロ−N6− [2−(N−メトキシ−N−メチ
ルアミノ)エチルコアデニン(化合物1)の合成 次のように、先ず側鎖ジアミンを合成し、これヲ2.6
−ジクロロプリンと反応させた。
Example 1 Synthesis of 2-chloro-N6-[2-(N-methoxy-N-methylamino)ethylcoadenine (compound 1) As follows, a side chain diamine was first synthesized, and this
- reacted with dichloropurine.

(1)N−[2−(N−メトキシルN−メチルアミノ〉
エチル]フタルイミドの合成 N、0−ジメチルヒドロキシルアミン塩酸塩390g 
(40,0mmol)を含むイソプロパツール懸濁液5
0m1に、5.56m1のトリエチルアミンを滴下した
。混合物は5分後には均一になった。これに2.45g
 (10,0mmol)のN−(2−ブロモエチル)フ
タルイミドを加え、29時間加熱還流した。
(1) N-[2-(N-methoxyl N-methylamino)
Synthesis of N,0-dimethylhydroxylamine hydrochloride 390g
Isopropanol suspension containing (40,0 mmol) 5
5.56 ml of triethylamine was added dropwise to 0 ml. The mixture became homogeneous after 5 minutes. 2.45g for this
(10.0 mmol) of N-(2-bromoethyl)phthalimide was added, and the mixture was heated under reflux for 29 hours.

反応混合物を室温に冷却後、200mlの飽和重曹水に
注ぎ、クロロポルムで抽出し、有機層を水洗した後、硫
酸マグネシウムで乾燥した。クロロホルムを留去し、残
渣をシリカゲルカラムクロマトグラフィーで分離、精製
した。30%ヘキサン−クロロホルムの展開により1.
37gのN−(2−クロロエチル)フタルイミドが溶出
し、さらにクロロホルムで展開すると0.96g(収率
41%)のN−[2−(N−メトキシ−N−メチルアミ
ノ)エチルコツタルイミドが白色結晶として得られた。
After cooling the reaction mixture to room temperature, it was poured into 200 ml of saturated sodium bicarbonate solution, extracted with chloroporm, and the organic layer was washed with water and dried over magnesium sulfate. Chloroform was distilled off, and the residue was separated and purified by silica gel column chromatography. 1. By development with 30% hexane-chloroform.
37g of N-(2-chloroethyl)phthalimide was eluted, and when further developed with chloroform, 0.96g (yield 41%) of N-[2-(N-methoxy-N-methylamino)ethylcottalimide was white. Obtained as crystals.

融点=130〜132℃ ’H−NMR(CDCl2.TMS内部標準);δ=2
.40 (s、 3N) 、 2.93 (t、 J=
6Hz、 2H) 。
Melting point = 130-132°C 'H-NMR (CDCl2.TMS internal standard); δ = 2
.. 40 (s, 3N), 2.93 (t, J=
6Hz, 2H).

3.53(s、3H)、 3.93(t、J=6Hz、
2H)。
3.53 (s, 3H), 3.93 (t, J=6Hz,
2H).

7、77 (m、 4H) ppm (2)N−メトキシ−N−メチルエチレンジアミンの合
成 上記(1)で得られたイミド1. 78g (7゜42
mmol)をメタノール3Qmlに溶かし、これに0.
408g  (8,16mmol)のヒドラジンハイド
レートを加え、6時間加熱還流した。
7,77 (m, 4H) ppm (2) Synthesis of N-methoxy-N-methylethylenediamine Imide obtained in the above (1) 1. 78g (7゜42
mmol) was dissolved in 3Qml of methanol, and 0.
408 g (8.16 mmol) of hydrazine hydrate was added, and the mixture was heated under reflux for 6 hours.

反応混合物を水浴で冷却し、生ずる固体を濾別した。濾
液をエバポレーターにより5℃の水浴で4mlに濃縮し
、これにエーテル10m1を加えて、析出する固体を濾
別した。濾液を濃縮後、常圧で蒸留して0.324g 
(収率42%、沸点97−101℃)のN−メトキシ−
N−メチルエチレンジアミンを得た。
The reaction mixture was cooled in a water bath and the resulting solid was filtered off. The filtrate was concentrated to 4 ml using an evaporator in a 5° C. water bath, 10 ml of ether was added thereto, and the precipitated solid was filtered off. After concentrating the filtrate, distill it under normal pressure to give 0.324g.
(yield 42%, boiling point 97-101°C) of N-methoxy-
N-methylethylenediamine was obtained.

’ H−N M R(CDCl2. TMS内部標準)
;δ=1.83(s、 2H)、 2.60(s、 3
H)、 2.78(m、 4tl)。
' H-NMR (CDCl2. TMS internal standard)
;δ=1.83(s, 2H), 2.60(s, 3
H), 2.78 (m, 4tl).

3、52 (s、 3H) ppm (3)2−クロロ−N6− [2−(N−メトキシ−N
−メチルアミノ)エチル]アデニンの合成2.6−ジク
ロロプリン0. 189g (1,OQmmol)とエ
チルジイソプロピルアミン0゜174ml (1,00
mmo 1)を3mlのn−ブタノールに溶かし、これ
に0.104g (1゜OQmmol)のN−メトキシ
−N−メチルエチレンジアミンを加えて、油浴上5時間
加熱還流した。
3,52 (s, 3H) ppm (3) 2-chloro-N6-[2-(N-methoxy-N
-Methylamino)ethyl] Adenine Synthesis 2.6-Dichloropurine 0. 189g (1,0Qmmol) and ethyldiisopropylamine 0°174ml (1,00
mmo 1) was dissolved in 3 ml of n-butanol, 0.104 g (1° OQ mmol) of N-methoxy-N-methylethylenediamine was added thereto, and the mixture was heated under reflux on an oil bath for 5 hours.

反応混合物を20m1の水に注ぎ、塩化メチレンで抽出
した後、有機層を硫酸マグネシウムで乾燥した。溶媒を
減圧下留去し、得られた固体を活性炭で脱色後、メタノ
ール−クロロホルムで再結晶して0.11()g(収率
43%)の標題化合物を無色柱状晶として得た。
The reaction mixture was poured into 20 ml of water, extracted with methylene chloride, and the organic layer was dried over magnesium sulfate. The solvent was distilled off under reduced pressure, and the resulting solid was decolorized with activated carbon and then recrystallized from methanol-chloroform to obtain 0.11 g (yield: 43%) of the title compound as colorless columnar crystals.

融点:232〜233℃(分解) ’H−NMR(DMSO−dll/CD、0D=2/1
.TMS内部標準);δ=2.58 (s、 3H) 
、 2.86 (t、 J=6Hz、 2H) 。
Melting point: 232-233°C (decomposition) 'H-NMR (DMSO-dll/CD, 0D=2/1
.. TMS internal standard); δ=2.58 (s, 3H)
, 2.86 (t, J=6Hz, 2H).

3、51 (S、 3H) 、 3.73 (tm、 
J=6Hz、 2H)8、00(s、 IH)I]J]
ln 赤外吸収スペクトル(KBr )  ;νmax =2
950”、 1590”、 1295’、 1250’
3,51 (S, 3H), 3.73 (tm,
J=6Hz, 2H)8,00(s, IH)I]J]
ln Infrared absorption spectrum (KBr); νmax = 2
950", 1590", 1295', 1250'
.

1040”、935’ car’ 紫外吸収スペクトル; λmax(H2O)   =212(20,100)、
270(15,700)nmλmax(0,1HMCI
) =2I3′h(20,500)、 274(14,
300)runλmax (0,lNNa[)H) =
276 (16,100) 、 286” (2,10
0) nm元素分析; C9Hl3CIN60  とし
ての計算値C:42.11%  )l:5.10%  
N:32.74%実測値 C:42.30%  H:4.98%  [33,02
%実施例2 2−クロロ−N’ −[3−(N−メトキシ−N−メチ
ルアミノ)プロピル]アデニン(化合物2)の合成 次のように、先ず側鎖ジアミンを合成し、これを2,6
−ジクロロプリンと反応させた。
1040", 935'car' Ultraviolet absorption spectrum; λmax (H2O) = 212 (20, 100),
270 (15,700) nmλmax (0,1HMCI
) =2I3'h(20,500), 274(14,
300) runλmax (0, lNNa[)H) =
276 (16,100), 286” (2,10
0) nm elemental analysis; Calculated value as C9Hl3CIN60 C: 42.11%) l: 5.10%
N: 32.74% Actual value C: 42.30% H: 4.98% [33,02
% Example 2 Synthesis of 2-chloro-N'-[3-(N-methoxy-N-methylamino)propyl]adenine (compound 2) First, a side chain diamine was synthesized as follows, and this was converted into 2, 6
- reacted with dichloropurine.

(1)N−[3−(N−メトキシ−N−メチルアミノ)
プロビルコツタルイミドの合成N、○−ジメチルヒドロ
キシルアミン塩酸塩390g (40,0mmol)を
含むイソプロパツール懸濁液5Qmlに、5.56m1
のトリエチルアミンを滴下した。混合物は5分後には均
一になった。これに2.68g (10,0mrnol
)のN−(3−ブロモプロピル)フタルイミドを加え、
33時間加熱還流した。
(1) N-[3-(N-methoxy-N-methylamino)
Synthesis of Provircostalimide 5.56 ml of isopropatol suspension containing 390 g (40.0 mmol) of N,○-dimethylhydroxylamine hydrochloride was added
of triethylamine was added dropwise. The mixture became homogeneous after 5 minutes. Add to this 2.68g (10,0mrnol
) of N-(3-bromopropyl)phthalimide,
The mixture was heated under reflux for 33 hours.

反応混合物を室温に冷却後、200mlの飽和重曹水に
注ぎ、クロロホルムで抽出し、有機層を水洗した後、硫
酸マグネシウムで乾燥した。クロロホルムを留去し、残
渣をシリカゲルカラムクロマトグラフィーで分離、精製
した。30%へヰサンークロロホルムの展開により1.
03gのN−(3−クロ゛ロプロピル)フタルイミドが
溶出し、さらにクロロホルムで展開すると1.21g(
収率53%)のN−[3−(N−メトキシ−N−メチル
アミン)プロビルコツタルイミドが白色結晶として得ら
れた。
After cooling the reaction mixture to room temperature, it was poured into 200 ml of saturated sodium bicarbonate solution, extracted with chloroform, and the organic layer was washed with water and dried over magnesium sulfate. Chloroform was distilled off, and the residue was separated and purified by silica gel column chromatography. 1. By developing with 30% hethane-chloroform.
03g of N-(3-chloropropyl)phthalimide was eluted, and when further developed with chloroform, 1.21g (
N-[3-(N-methoxy-N-methylamine)probylcotta imide was obtained as white crystals in a yield of 53%.

融点:55〜57℃ ’H−NMR(CDCl2.TMS内部標準);64、
93<quin、 J=6Hz、 2H)、 2.55
(s、 3H)。
Melting point: 55-57°C 'H-NMR (CDCl2.TMS internal standard); 64,
93<quin, J=6Hz, 2H), 2.55
(s, 3H).

2、68 (t、 J=6Hz、 2H) 、 3.5
2 (s、 3H) 。
2,68 (t, J=6Hz, 2H), 3.5
2 (s, 3H).

3.80(t、J=6Hz、2H)、 7.75(m、
4H)ppm(2)2−クロロ−N6− [3−(N−
メトキシ−N−メチルアミン)プロピル]アデニンの合
成0.540g (2,18mmol)のN−[3−(
N−メトキシ−N−メチルアミノ)プロピルコツタルイ
ミドを20m1のメタノールに溶かし、これに0.12
7m1  (2,62mmol)のヒドラジンハイドレ
ートを加え、6時間加熱還流した。
3.80 (t, J=6Hz, 2H), 7.75 (m,
4H) ppm (2) 2-chloro-N6- [3-(N-
Synthesis of methoxy-N-methylamine)propyl]adenine 0.540g (2.18mmol) of N-[3-(
Dissolve N-methoxy-N-methylamino)propylcottalimide in 20ml of methanol, add 0.12ml of
7 ml (2.62 mmol) of hydrazine hydrate was added, and the mixture was heated under reflux for 6 hours.

反応混合物を室温に冷却後、これにエーテル30m1を
加え、0℃に1時間放置して充分に固体を析出させた。
After the reaction mixture was cooled to room temperature, 30 ml of ether was added thereto, and the mixture was left at 0° C. for 1 hour to sufficiently precipitate a solid.

吸引濾過により固体を除き、濾液を硫酸ナトリウムで乾
燥後、エバポレーターにより2mlにまで濃縮した。
Solids were removed by suction filtration, and the filtrate was dried over sodium sulfate and concentrated to 2 ml using an evaporator.

この濃縮液を5mlのインプロパツールに溶カし、これ
に2.6−ジクロロプリン0.095g(0,503m
mo 1)とエチルジイソプロピルアミン0.088m
1を加えて、油浴上5時間加熱還流した。
This concentrated solution was dissolved in 5 ml of impropatul, and 0.095 g of 2,6-dichloropurine (0,503 ml
mo 1) and ethyldiisopropylamine 0.088m
1 was added thereto, and the mixture was heated under reflux on an oil bath for 5 hours.

析出した結晶を濾別した後、メタノールから再結晶して
0.049g (収率8%)の標題化合物を白色粉末と
して得た。
The precipitated crystals were filtered off and then recrystallized from methanol to obtain 0.049 g (yield: 8%) of the title compound as a white powder.

融点=230〜231℃(分解) ’ HN M R(DMSO−ds、 TMS内部標準
);δ=1.33(quin、 J=6Hz、 2H)
、 2.50(S、 3H)。
Melting point = 230-231°C (decomposition) 'HNMR (DMSO-ds, TMS internal standard); δ = 1.33 (quin, J = 6Hz, 2H)
, 2.50 (S, 3H).

2、65 (t、 J=6Hz、 2H) 、 3.4
4 (s、 3N) 。
2,65 (t, J=6Hz, 2H), 3.4
4 (s, 3N).

3、60(m、 2H)、 8.08(s、 IH)p
pm赤外吸収スペクトル(KBr )  ;vmax 
=2930v′、 2780”、 1585’、 15
40’、 1420’。
3,60(m, 2H), 8.08(s, IH)p
pm infrared absorption spectrum (KBr); vmax
=2930v', 2780'', 1585', 15
40', 1420'.

1335’″、 1240’″、 1125’、 10
30’、 910’cm ’紫外吸収スペクトル; λmax (H2O)    212 (24,700
) 、 271 (18,700) nmλmax(0
,INHC’l)  212(23,000)、272
(16,400)nmλmax (0,lNNa0H)
 277 (16,900) 、 283sh (13
,900) nm元素分析: C+otLsCINsO
としての計算値C:44.37%  H:5.58% 
 N:31.04%実測値 C:44.51%  )l:5.53%  N:30.
82%実施例3 N6− [2−(N−メトキシ−N−メチルアミノ)エ
チル]アデニンリボシド(化合物3)の合成 6−クロロプリンリボシド0.110g(0゜384m
mo 1)、N−メトキシ−N−メチルエチレンジアミ
ン0.130g (1,21mmol)とエチルジイソ
プロピルアミン0.174m1(1,00mmo 1)
を5mlのn−ブタノールに溶かし、油浴上5時間加熱
還流した。
1335''', 1240''', 1125', 10
30', 910'cm' Ultraviolet absorption spectrum; λmax (H2O) 212 (24,700
), 271 (18,700) nmλmax(0
, INHC'l) 212 (23,000), 272
(16,400)nmλmax (0,lNNaOH)
277 (16,900), 283sh (13
,900) nm elemental analysis: C+otLsCINsO
Calculated value as C: 44.37% H: 5.58%
N: 31.04% Actual value C: 44.51% )l: 5.53% N: 30.
82% Example 3 Synthesis of N6-[2-(N-methoxy-N-methylamino)ethyl]adenine riboside (compound 3) 6-chloropurine riboside 0.110 g (0°384 m
mo 1), N-methoxy-N-methylethylenediamine 0.130 g (1,21 mmol) and ethyldiisopropylamine 0.174 ml (1,00 mmol 1)
was dissolved in 5 ml of n-butanol and heated under reflux on an oil bath for 5 hours.

溶媒を減圧下留去し、残渣をシリカゲルカラムクロマト
グラフィー(展開剤:エタノール/クロロホルム=1/
4)で精製し、0.034g (収率25%)の標題化
合物を白色固体として得た。
The solvent was distilled off under reduced pressure, and the residue was subjected to silica gel column chromatography (developing agent: ethanol/chloroform = 1/
4) to obtain 0.034 g (yield 25%) of the title compound as a white solid.

融点=127〜129℃ ’H−NMR(CD、00/CDC13=1/3.TM
S 内111) ;δ=2.63 (s、 3H) 、
 2.90 (t、 J=6Hz、 2H) 、 3.
54 (s、 3H) 。
Melting point = 127-129°C 'H-NMR (CD, 00/CDC13 = 1/3.TM
S inside 111); δ=2.63 (s, 3H),
2.90 (t, J=6Hz, 2H), 3.
54 (s, 3H).

3、80 (m、 4H)、 4.1−4.4(m、 
2H)、 4.91 (t、 J=6Hz、 IH)。
3,80 (m, 4H), 4.1-4.4 (m,
2H), 4.91 (t, J=6Hz, IH).

5、85(d、 J=6Hz、 IH)、 8.00(
s、 LH)、 8.20(s、 LH)ppm赤外吸
収スペクトル(KBr )  ;vmax =3100
”、 2910’、 1605’、 1585’、 1
330”。
5, 85 (d, J=6Hz, IH), 8.00 (
s, LH), 8.20 (s, LH) ppm infrared absorption spectrum (KBr); vmax = 3100
", 2910', 1605', 1585', 1
330”.

1285″、 1085″、 1040’、 755°
cm紫外吸収スペクトル; λmax(H2O)   =210(20,400)、
266(21,000)nmλmax (0,1NHC
I) =266 (19,100) nmλmax (
0,1NNaOH) =266 (21,400) n
m元素分析+Cl4H2□〜s[]s  としての計算
値C:47.45%  H:6.26%  N:23.
72%実測値 C:47.58%  H:6.25%  N+23.4
5%実施例4 2−クロロ−N6−[2−(N〜メトキシ−N−メチル
アミン)エチル]アデニン塩酸塩(化合物4)の製造 0.270g (1,05mm○1)の2−クロロ−N
6− [2−(N−メトキシ−N−メチルアミノ)エチ
ル]アデニンを15m1のエタノールに溶かし、これに
1. 05m1のlNHClを加えた。
1285'', 1085'', 1040', 755°
cm ultraviolet absorption spectrum; λmax (H2O) = 210 (20,400),
266 (21,000) nmλmax (0,1NHC
I) =266 (19,100) nmλmax (
0,1NNaOH) =266 (21,400) n
Calculated value as m elemental analysis + Cl4H2□~s[]s C: 47.45% H: 6.26% N: 23.
72% actual value C: 47.58% H: 6.25% N+23.4
5% Example 4 Preparation of 2-chloro-N6-[2-(N~methoxy-N-methylamine)ethyl]adenine hydrochloride (compound 4) 0.270 g (1,05 mm○1) of 2-chloro- N
Dissolve 6-[2-(N-methoxy-N-methylamino)ethyl]adenine in 15 ml of ethanol and add 1. 05 ml of 1N HCl was added.

溶媒を減圧下留去し、残渣をクロロホルムで洗浄し、0
.290gの粗生成物を得た。これをエタノールから再
結晶し、標題化合物0.275g(収率8′9%)を無
色柱状晶として得た。
The solvent was distilled off under reduced pressure, and the residue was washed with chloroform.
.. 290 g of crude product was obtained. This was recrystallized from ethanol to obtain 0.275 g (yield: 8'9%) of the title compound as colorless columnar crystals.

融点:182〜184℃(分解) ’ H−N M R(DMSO−d6. TMS内部標
準);δ=2.72 (S、 3H) 、 3.07 
(t、 J=5Hz、 2N) 。
Melting point: 182-184°C (decomposition) 'H-NMR (DMSO-d6. TMS internal standard); δ = 2.72 (S, 3H), 3.07
(t, J=5Hz, 2N).

3、61 (s、 3H) 、 3.73 (m、 2
H) 、 8.60 (br、 LH) 。
3,61 (s, 3H), 3.73 (m, 2
H), 8.60 (br, LH).

8、71 (s、 IH) ppm 赤外吸収スペクトル(KBr )  ;νmax =2
920’、 2500br、 2150”、 1600
’、 1550”。
8,71 (s, IH) ppm Infrared absorption spectrum (KBr); νmax = 2
920', 2500br, 2150'', 1600
', 1550''.

1235’、 1140”、 925°cm−’元素分
析; C,H,4C12N6[1としての計算値C:3
6.87%  H:4.81%  N:28.67%実
測値 C:36.99%  H:4.83%  N:28.3
6%試験例1 クロロフィル保持効果によるサイトカイ
ニン活性試験 培土を詰めた苗箱にイネの種子(品種:南東11号)を
播種し、ガラス室内(昼間25℃/夜間15°C)で約
1ケ月間生育させた。
1235', 1140'', 925°cm-' Elemental analysis; Calculated value as C, H, 4C12N6 [1 C: 3
6.87% H: 4.81% N: 28.67% Actual value C: 36.99% H: 4.83% N: 28.3
6% Test Example 1 Cytokinin activity test based on chlorophyll retention effect Rice seeds (variety: Southeast No. 11) were sown in a seedling box filled with soil and kept in a glass room (25°C during the day/15°C at night) for about 1 month. I let it grow.

第6葉展開時の4葉の中央部から、長さ1cmの葉片を
切り取った。所定濃度の供試化合物を含む被験液2ml
を加えた内径32mmのガラス管びんに、切り取った葉
片5枚を1組として浮かべた。暗黒下、30℃に3日間
置いた後、葉片を80%エタノール10m1の入った試
験管に入れ、80℃の温浴に20分間浸漬して、クロロ
フィルを抽出した。
A leaf piece with a length of 1 cm was cut from the center of the fourth leaf when the sixth leaf was expanded. 2 ml of test solution containing the specified concentration of test compound
A set of five cut leaf pieces were floated in a glass tube with an inner diameter of 32 mm. After being left at 30°C in the dark for 3 days, the leaf pieces were placed in a test tube containing 10ml of 80% ethanol and immersed in a hot bath at 80°C for 20 minutes to extract chlorophyll.

冷却後、80%エタノールを加えて、10m1とし、6
65nmの波長で吸光度を測定した。
After cooling, add 80% ethanol to make 10ml.
Absorbance was measured at a wavelength of 65 nm.

無処理区に対する処理区のクロロフィル保持効果による
老化抑制率を次式により求めた。
The aging suppression rate due to the chlorophyll retention effect in the treated plot compared to the untreated plot was calculated using the following formula.

結果を表−2に示す。The results are shown in Table-2.

濃度 (mg/l) 試験例2 ヒモゲイドウのベタシアニンの合成促進によ
るサイトカイニン活性試験 プラスチックの容器(19X28cm)に、濾紙を二重
に敷き、60m1の蒸留水で湿らせた。
Concentration (mg/l) Test Example 2 Cytokinin Activity Test by Promoting the Synthesis of Betacyanin in Pygmy Corylus A plastic container (19 x 28 cm) was lined with two layers of filter paper and moistened with 60 ml of distilled water.

ヒモゲイドウの種子を濾紙上にまき、暗黒下、27℃に
3日間保ち、発芽させた。均一な大きさの芽生えを選び
、胚軸の上部を切断し、種皮を取り除いた。
Seeds of Himogeido were sown on filter paper and kept in the dark at 27°C for 3 days to germinate. Shoots of uniform size were selected, the upper part of the hypocotyl was cut, and the seed coat was removed.

この子葉と、胚軸の上部3〜4mmを検定に用いた。内
径32mmのガラス管びんに、濾紙を二重にしき、所定
濃度の供試化合物と、0.5g/lのチロシンを含む0
.0065Mリン酸カリウム緩衝液(pH6,3)をl
 m 1加え、1o本の子葉切片を並べ、暗黒下、27
℃に20時間保った。子葉切片10本を3mlの蒸留水
の入った試験管に入れ、凍結、解凍を3度くり返してベ
タシアニンを抽出し、その溶液の吸光度を測定し、波長
542nmと620nmの吸光度の差から色素量を定量
した。
This cotyledon and the upper 3 to 4 mm of the hypocotyl were used for the assay. A glass tube with an inner diameter of 32 mm was lined with filter paper, and the test compound at a predetermined concentration and 0.0 g/l containing 0.5 g/l of tyrosine were placed in a glass tube with an inner diameter of 32 mm.
.. 0065M potassium phosphate buffer (pH 6,3)
Add 1 m, arrange 10 cotyledon sections, and place in the dark at 27
It was kept at ℃ for 20 hours. Ten cotyledon sections were placed in a test tube containing 3 ml of distilled water, frozen and thawed three times to extract betacyanin, the absorbance of the solution was measured, and the amount of pigment was determined from the difference in absorbance at wavelengths of 542 nm and 620 nm. Quantitated.

結果を表−3に示す。The results are shown in Table-3.

試験例3 イネにおける吸収、移動性に関する試験;イ
ネ葉片に対する化合物1とベンジルアデニンの浸透クロ
ロフィル保持効果 イネの種子(品種:南東11号)を培土を詰めた苗箱に
播種し、ガラス室内(昼間25℃/夜間15℃)で約1
カ月間生育させた。
Test Example 3 Test on absorption and mobility in rice; Penetration and chlorophyll retention effect of Compound 1 and benzyladenine on rice leaf pieces Rice seeds (variety: Southeast No. 11) were sown in seedling boxes filled with potting soil, and placed in a glass room (during the day). Approximately 1 at 25℃/15℃ at night)
It was grown for a month.

7葉展開時の5葉の中央部から、長さ33mmの葉片を
切りとった。直径9cmのシャーレに円形濾紙1枚を敷
き、2.5mlの蒸留水で湿らせた。この上にスライド
グラス1枚をおき、このスライドグラスの上に、切りと
った5枚の葉片を、葉片の表面が上になるように並べた
。この葉片の中央に、供試化合物を0.D2%ソルボ−
ルー8214(東邦化学工業株式会社製)水溶液で溶か
して10mg/lの濃度に調製した検液10μlを載せ
た。シャーレに蓋をした後、暗黒下、25℃に5日間置
き、被検液を載せたところを中心に検液のクロロフィル
保持効果によって残った緑色の部分の長さを測定した。
A leaf piece with a length of 33 mm was cut from the center of the 5th leaf when the 7th leaf was expanded. A piece of circular filter paper was placed in a Petri dish with a diameter of 9 cm and moistened with 2.5 ml of distilled water. A slide glass was placed on top of this, and five cut leaf pieces were arranged on top of this slide glass so that the surface of the leaf pieces was facing upward. 0.0% of the test compound was placed in the center of this leaf. D2% Sorbo
10 μl of a test solution prepared by dissolving Ru 8214 (manufactured by Toho Chemical Industry Co., Ltd.) in an aqueous solution to a concentration of 10 mg/l was placed on the plate. After the petri dish was covered, it was placed in the dark at 25° C. for 5 days, and the length of the green part remaining due to the chlorophyll retention effect of the test solution was measured, centering on the area where the test solution was placed.

なお、無処理区は、002%ツルポール−8214(東
邦化学工業株式会社製)10μmを葉片の中央に載せた
。試験は2反復で行った。
In addition, for the untreated plot, 10 μm of 002% Tsurupol-8214 (manufactured by Toho Chemical Industry Co., Ltd.) was placed on the center of the leaf. The test was performed in two replicates.

結果を表−4に示す。同じ濃度での比較では、ベンジル
アデニンより化合物1の方が緑色部が大きく広がってお
り、吸収、移動性のよいことが窺われた。
The results are shown in Table 4. In comparison at the same concentration, Compound 1 had a larger green area than benzyladenine, indicating better absorption and mobility.

参考例 本発明化合物および従来知られているサイトカイニン物
質について、水に対する溶解度を測定した。結果は、次
の表に示すように、従来良く知られた代表的な物質に比
べ、優れた溶解性を示した。
Reference Example The solubility in water of the compound of the present invention and a conventionally known cytokinin substance was measured. As shown in the following table, the results showed superior solubility compared to conventionally well-known representative substances.

[発明の効果] 本発明に係るアデニン誘導体は、サイトカイニン作用を
示すとともに、従来の合成品よりも水に対する溶解性、
生体への浸透性に優れ、植物生長調節剤などとしての使
用が期待される。
[Effects of the Invention] The adenine derivative according to the present invention not only exhibits cytokinin action, but also has higher water solubility and better water solubility than conventional synthetic products.
It has excellent permeability into living organisms and is expected to be used as a plant growth regulator.

ベンジルアデニン ゼアチン カイネチン 0、24 0、18 14、2 1.3 X1O−3 0、14 X10−3benzyladenine Zeatin kinetin 0, 24 0, 18 14, 2 1.3 X1O-3 0, 14 X10-3

Claims (1)

【特許請求の範囲】 下記の一般式 I で表されるアデニン誘導体および一般
式IIで表されるアデニン誘導体の塩。 ▲数式、化学式、表等があります▼〔 I 〕 ▲数式、化学式、表等があります▼〔II〕 (ただし、一般式 I および一般式IIにおいて、nは2
または3の整数、Xは水素または塩素原子、Yは水素原
子または2−リボシル基を示す。ただし、XとYがとも
に水素原子の場合を除く。一般式IIにおいて、Zは当量
の塩酸、臭化水素酸、硫酸、硝酸、りん酸、ギ酸または
酢酸である。)
[Claims] An adenine derivative represented by the following general formula I and a salt of an adenine derivative represented by the general formula II. ▲There are mathematical formulas, chemical formulas, tables, etc.▼[I] ▲There are mathematical formulas, chemical formulas, tables, etc.▼[II] (However, in general formula I and general formula II, n is 2
or an integer of 3, X represents a hydrogen atom or a chlorine atom, and Y represents a hydrogen atom or a 2-ribosyl group. However, this excludes the case where both X and Y are hydrogen atoms. In general formula II, Z is an equivalent amount of hydrochloric acid, hydrobromic acid, sulfuric acid, nitric acid, phosphoric acid, formic acid or acetic acid. )
JP2106605A 1990-04-24 1990-04-24 New adenine derivatives Expired - Lifetime JP3019360B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2106605A JP3019360B2 (en) 1990-04-24 1990-04-24 New adenine derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2106605A JP3019360B2 (en) 1990-04-24 1990-04-24 New adenine derivatives

Publications (2)

Publication Number Publication Date
JPH045290A true JPH045290A (en) 1992-01-09
JP3019360B2 JP3019360B2 (en) 2000-03-13

Family

ID=14437760

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2106605A Expired - Lifetime JP3019360B2 (en) 1990-04-24 1990-04-24 New adenine derivatives

Country Status (1)

Country Link
JP (1) JP3019360B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116535407A (en) * 2023-05-08 2023-08-04 河南省精细化工研究院有限公司 Preparation process of plant endogenous cytokinin enadenine

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116535407A (en) * 2023-05-08 2023-08-04 河南省精细化工研究院有限公司 Preparation process of plant endogenous cytokinin enadenine

Also Published As

Publication number Publication date
JP3019360B2 (en) 2000-03-13

Similar Documents

Publication Publication Date Title
AU2013293973B2 (en) 4-[5-(Pyridin-4-yl)-1H-1,2,4-Triazol-3-yl]Pyridine-2-Carbonitrile Crystalline Polymorph and Production Method Therefor
JP2022530812A (en) Crystal form of Wee1 inhibitor compound and its applications
JPWO2001092231A1 (en) Rice blast control agent
CN119013269A (en) Crystal form of alkynyl pyridine compound and preparation method thereof
CN110041222B (en) Thymoquinone derivative, intermediate, preparation method and application thereof
JP2979469B2 (en) New genistein derivatives
CN112047880B (en) Azaflavone derivatives and application thereof as antitumor drugs
EP0508777A2 (en) Novel adenine derivatives and their use as plant growth regulators
CN117342990B (en) A sulfonamide compound, a preparation method and application thereof, a pesticide preparation, a pharmaceutical
JPH045290A (en) New adenine derivative
CN110041204A (en) A kind of resveratrol nitroethylene class compound and its preparation method and application
US5399590A (en) Quaternary ammonium salts and pharmaceutical compositions containing them
JPH02255682A (en) Adenine derivative
CN117342989B (en) Anthracene-9,10-dione compounds and their preparation methods and applications, applications of sulfonamide compounds, and a pharmaceutical
CN110194741B (en) 4-Benzoylpiperazine-3-nitro-1,8-naphthalimide derivatives and their preparation method and application
JPH05294967A (en) New adenine derivative
JPH02255683A (en) Adenine derivative
EP0390515B1 (en) Novel adenine derivatives and their use as agents for increasing crop yields
JPH05320164A (en) Novel adenine derivative
JPH05112569A (en) Novel adenine derivative
CN105130896B (en) A class of naphthalimide derivatives containing a thiourea substituent, its preparation method and application
JPH0238588B2 (en) SHINKIHIDANTOINKAGOBUTSU
CN101781244A (en) Preparation method of 4-bromo-N- (pyridine-2-methyl) naphthalene-1-sulfonamide compound
JPS59501065A (en) Method for producing phenolamide
JPWO2001062769A1 (en) Method for producing indolopyrrolocarbazole derivatives, intermediates therefor, and method for producing the same